Harness the latest AI-driven automation in cell culture
Discover how cutting-edge AI-driven automation systems are transforming cell culture workflows and lab productivity
13 May 2026
Advances in in vitro cell culture have transformed cell biology, enabling researchers to work at greater scale and develop increasingly complex models of human disease. The rise of 3D culture systems, including patient‑derived induced pluripotent stem cells (iPSCs) and organoids, has expanded the potential of drug discovery and disease modeling by more closely replicating human physiology.
However, these advanced systems remain difficult to adopt. Manual cell culture workflows are labor‑intensive, time‑sensitive, and prone to operator‑dependent variability, while traditional 2D cultures persist due to their simplicity and established protocols. Such inconsistencies can limit reproducibility, slow research progress, and increase the risk of costly failures in drug development.
This SelectScience guide highlights how AI‑driven automated cell culture solutions from Molecular Devices® are addressing these challenges.
Download your copy to explore applications such as:
- 2D adherent and suspension culture
- A full iPSC workflow
- 3D cancer spheroids
- Intestinal organoids
- Brain organoids
- Cardiac organoids
- Industrial-scale organoid production
Resource details:
- Document type: SelectScience guide
- Page count: 73
- Read time: 110 mins
- Edition: 1st
Related products
Request Quote for All Products
CellXpress.ai Automated Cell Culture System
Molecular Devices®The CellXpress.ai™ Automated Cell Culture System is an AI-driven cell culture innovation hub that gives your team total control over demanding cell culture feeding and passaging schedules—eliminating time in the lab while maintaining a 24/7 schedule for growing and scaling multiple stem cell lines, spheroids, or organoids.
3D Ready Organoid Expansion Service
Molecular Devices®Unique service that enables you to expand your own organoid lines to a scale large enough to suit your individual requirements. Generate more than six million assay-ready, reproducible organoid models to support your compound screening, cell model creation, or other applications.